Type of Deal: Strategic minority acquisition (6% stake)
Stake/Capacity: 6% stake in the LLP. The target hospital has a current capacity of 316 beds with potential for expansion to over 500 beds.
Deal Value: ₹15 Crore (Rupees Fifteen Crore only) by way of primary infusion
Funding Source: Cash consideration from internal resources
Financial Impact: Not explicitly disclosed in terms of revenue contribution, EBITDA impact, or accretion/dilution. The target entity reported FY26 turnover of ₹80.42 crore and PAT of -₹23.59 crore with networth of ₹116.42 crore.
Timeline: Expected completion on or before 31-10-2026
Strategic Rationale: KIMS is already the exclusive Operations and Management (O&M) partner for the hospital, providing high-quality medical services under the "KIMS-UAIMS" brand. The acquisition represents a strategic investment to strengthen this partnership and enhance operational efficiency. The hospital is described as a state-of-the-art quaternary care facility with one of the highest floor-area-to-bed ratios in the region.
Approval Status: Board-approved on 06th October, 2026
Reference Regulation: SEBI Regulation 30 of Listing Obligations and Disclosure Requirements Regulations, 2015, read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Additional Details:
The transaction does not qualify as a related party transaction
